Immunogenicity of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients
Open Access
- 17 April 2021
- journal article
- letter
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 21 (8), 2913-2915
- https://doi.org/10.1111/ajt.16607
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant RecipientsJAMA, 2021
- Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assaysPublished by Cold Spring Harbor Laboratory ,2021
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine, 2020
- Factors associated with COVID-19-related death using OpenSAFELYNature, 2020
- Influenza Vaccination in the Organ Transplant Recipient: Review and Summary RecommendationsAmerican Journal of Transplantation, 2011